Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
This company's line of business includes the manufacturing, fabricating, or processing of drugs in pharmaceutical preparations for human or veterinary use.
Franco-Indian Pharmaceuticals Private Limited, is an unlisted private company incorporated on 01 May, 1959. It is classified as a private limited company and is located in , Maharashtra. It's authorized share capital is INR 2.00 cr and the total paid-up capital is INR 46.25 lac.
Read more
** All rupee values in INR crores. Based on March 2023 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Santosh Mohan Chavan | 09097972 | 4 years |
Director | Jagdish Purushottamdas Mehta | 00053296 | 11 years |
Managing Director | Pascal Postel
Shareholder
|
00026853 | 28 years |
Director | Lalsa Balgovind Yadav | 00055974 | 20 years |
Director | Ajit Anant Mangalvede | 10140076 | 2 years |
Director | Alexandre Johan Postel | 03588038 | 3 years |
Additional Director | Errol James Desouza | 00053201 | 3 years |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
FRANCO INDIAN RESEARCH PRIVATE LIMITED |
Active
|
1.0 L | 2 | Tamil Nadu |
PRINCEPS PHARMACEUTICALS PRIVATE LIMITED |
Active
|
1.0 L | 2 | Tamil Nadu |
FRANCO INDIAN MEDICARE PVT LTD |
Active
|
1.0 L | 2 | West Bengal |
FRANCO INDIAN THERAPEUTICS PVT. LTD. |
Active
|
1.0 L | 2 | West Bengal |
LABORATOIRES GRIFFON PRIVATE LIMITED |
Active
|
32.1 L | 3 | West Bengal |
FRANCO-INDIAN HOLDINGS PRIVATE LIMITED |
Active
|
7.4 Cr | 2 | Maharashtra |
WARDEX PHARMACEUTICALS PRIVATE LIMITED |
Active
|
42.0 L | 4 | |
MEDIBEST INVESTMENTS PRIVATE LIMITED |
Amalgamated
|
11.5 L | 2 | Maharashtra |
PHARMABEST INVESTMENTS PRIVATE LIMITED |
Amalgamated
|
11.5 L | 1 | Maharashtra |
CURABEST INVESTMENTS PRIVATE LIMITED |
Amalgamated
|
11.5 L | 2 | Maharashtra |
FRANCO-INDIAN REMEDIES PRIVATE LIMITED |
Active
|
14.9 L | 1 | Tamil Nadu |
Read more
The incorporation date of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED is 01 May, 1959
The authorized share capital of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 2.0 Cr.
The paid-up capital of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 46.2 L.
The registered address of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED is 20 DR E MOSES ROAD, MUMBAI, Maharashtra, India, 400011 - 400011
The CIN number of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED is U24239MH1959PTC011347.